Back to Treatments

Treatment

Oral H1 Antihistamines (2nd Generation)

1
Conditions
1
Trials
80K
Participants
82%
Average Safety

Condition Evidence

Allergic Rhinitis

1 trials · 80K participants

75% effectiveness · 82% safety
Oral H1 Antihistamines (2nd Generation) | DFDA